Literature DB >> 22421029

Serial assessment of right ventricular volume and function in surgically palliated hypoplastic left heart syndrome using real-time transthoracic three-dimensional echocardiography.

Shelby Kutty1, Bridget A Graney, Nee Scze Khoo, Ling Li, Amanda Polak, Paul Gribben, James M Hammel, Jeffrey F Smallhorn, David A Danford.   

Abstract

BACKGROUND: Right ventricular (RV) failure is a major cause of morbidity and mortality in patients with hypoplastic left heart syndrome (HLHS), but the longitudinal course of RV volumes through staged palliation (SP) has not been previously investigated. The aim of this study was to evaluate RV volume and function longitudinally through SP of HLHS using real-time three-dimensional echocardiography.
METHODS: A total of 18 subjects with HLHS were prospectively studied at four time points from diagnosis through stage 2 (SP2). Real-time three-dimensional echocardiographic full-volume data sets were acquired in high-frame rate mode with electrocardiographic gating. Volumetric and functional analyses were performed using a semiautomatic contour detection algorithm. Eighteen age-matched and sex-matched normal infants (aged 0-6 months) were studied at comparable time points as controls.
RESULTS: Presurgical examinations (pre-stage 1 [SP1]; n = 18) were performed at a mean age of 4 days, post-SP1 examinations (n = 17) at a mean age of 20 days, pre-SP2 examinations (n = 14) at a mean age of 4.6 months, and post-SP2 examinations (n = 14) at a mean age of 5.5 months, constituting a total of 63 examinations. The mean values of RV end-diastolic volume indexed to body surface area (EDVi) at the four time points were 87 ± 30, 104 ± 39, 112 ± 34, and 102 ± 35 mL/m(2), respectively. There was an increase in EDVi (P = .024) from pre-SP1 to post-SP1 but no significant change between post-SP1 and pre-SP2. The decrease in EDVi after SP2 did not reach statistical significance. Mean RV ejection fractions (EFs) were 50 ± 5%, 45 ± 5%, 46 ± 5%, and 38 ± 4%, respectively. There was a trend toward decreasing EF throughout SP, with statistically significant decreases from pre-SP1 to post-SP1 (P = .003) and from pre-SP2 to post-SP2 (P < .001). In normal infants, the mean RV EDVi was 50 ± 10 mL/m(2) (approximately half that of patients with HLHS), and the mean EF was 51 ± 3%. There was good interobserver agreement for EDVi, end-systolic volume indexed to body surface area, and EF.
CONCLUSIONS: Real-time three-dimensional echocardiography is a reproducible means for evaluating RV volumes and EFs in patients with HLHS. Indexed RV diastolic volume remains stable to slightly increased, and RV EF deteriorates as the first two stages of surgical palliation are accomplished. The findings of this study highlight the adverse physiology of HLHS, which deteriorates even among early survivors despite SP.
Copyright © 2012 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22421029     DOI: 10.1016/j.echo.2012.02.008

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  9 in total

Review 1.  Ventricular performance after surgery for a congenital heart defect as assessed using advanced echocardiography: from doppler flow to 3D echocardiography and speckle-tracking strain imaging.

Authors:  Liselotte M Klitsie; Arno A W Roest; Nico A Blom; Arend D J ten Harkel
Journal:  Pediatr Cardiol       Date:  2014-01       Impact factor: 1.655

2.  Right Ventricular Remodeling in Hypoplastic Left Heart Syndrome is Minimally Impacted by Cardiopulmonary Bypass: A Comparison of Norwood vs. Hybrid.

Authors:  Kandice Mah; Jesus Serrano Lomelin; Timothy Colen; Edythe B Tham; Lily Lin; Luke Eckersley; Jeffrey F Smallhorn; Harald Becher; Luc Mertens; Nee Scze Khoo
Journal:  Pediatr Cardiol       Date:  2020-10-10       Impact factor: 1.655

3.  Evolution of Ventricular Energetics in the Different Stages of Palliation of Hypoplastic Left Heart Syndrome: A Retrospective Clinical Study.

Authors:  A Di Molfetta; R Iacobelli; P Guccione; L Di Chiara; M Rocchi; F Cobianchi Belisari; M Campanale; M G Gagliardi; S Filippelli; G Ferrari; A Amodeo
Journal:  Pediatr Cardiol       Date:  2017-08-22       Impact factor: 1.655

4.  Multicenter study comparing shunt type in the norwood procedure for single-ventricle lesions: three-dimensional echocardiographic analysis.

Authors:  Gerald R Marx; Girish Shirali; Jami C Levine; Lin T Guey; James F Cnota; Jeanne M Baffa; William L Border; Steve Colan; Gregory Ensing; Mark K Friedberg; David J Goldberg; Salim F Idriss; J Blaine John; Wyman W Lai; Minmin Lu; Shaji C Menon; Richard G Ohye; David Saudek; Pierre C Wong; Gail D Pearson
Journal:  Circ Cardiovasc Imaging       Date:  2013-10-04       Impact factor: 7.792

Review 5.  Innovation in 3D Echocardiographic Imaging.

Authors:  Pei-Ni Jone; Nee Khoo
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-01-19

Review 6.  Multimodality Imaging in Congenital Heart Disease: an Update.

Authors:  Uyen T Truong; Shelby Kutty; Craig S Broberg; David J Sahn
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012

7.  Association of Digoxin With Preserved Echocardiographic Indices in the Interstage Period: A Possible Mechanism to Explain Improved Survival?

Authors:  Maria Batsis; Lazaros Kochilas; Alvin J Chin; Michael Kelleman; Eric Ferguson; Matthew E Oster
Journal:  J Am Heart Assoc       Date:  2021-12-02       Impact factor: 6.106

8.  Serial Assessment of Right Ventricular Deformation in Patients With Hypoplastic Left Heart Syndrome: A Cardiovascular Magnetic Resonance Feature Tracking Study.

Authors:  Luca Mitch Kanngiesser; Sandra Freitag-Wolf; Simona Boroni Grazioli; Dominik Daniel Gabbert; Jan Hinnerk Hansen; Anselm Sebastian Uebing; Inga Voges
Journal:  J Am Heart Assoc       Date:  2022-04-27       Impact factor: 6.106

9.  Loss of Ventricular Function After Bidirectional Cavopulmonary Connection: Who Is at Risk?

Authors:  Marie Vincenti; M Yasir Qureshi; Talha Niaz; Drew K Seisler; Timothy J Nelson; Frank Cetta
Journal:  Pediatr Cardiol       Date:  2020-08-11       Impact factor: 1.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.